Company News

  • Olympus Exits Microscopy Market

    Olympus Corporation and EVIDENT Co., Ltd., a wholly-owned subsidiary of Olympus announced today that Olympus concluded a definitive agreement with Bain Capital Private Equity, LP, regarding the transfer of Evident. Based on this agreement, all shares of Evident will be transferred to Bain Capital on January 4, 2023, subject to regulatory approvals and closing conditions. […]

  • PerkinElmer to Focus on Life Sciences & Diagnostics

    PerkinElmer has announced its intention to divest its Applied, Food and Enterprise Services businesses to New Mountain Capital, a private equity firm, for a total consideration of $2.45 billion in cash, $2.30 billion of which will be received at the closing and $150 million of which will be payable contingent on the exit valuation New […]

  • Malvern Panalytical Acquires Creoptix AG

    Malvern Panalytical has announced its acquisition of Creoptix AG, a specialist bioanalysis sensor company. The acquisition forms a critical part of Malvern Panalytical’s strategy to expand its capabilities in support of drug discovery. Creoptix provides cutting edge tools for molecular interaction analysis through its WAVEsystem of next-generation bioanalytical instruments. The WAVEsystem offers a breakthrough level […]

  • PerkinElmer Agrees to Acquire SIRION Biotech

    PerkinElmer Inc. has announced it has entered into an agreement to acquire SIRION Biotech GmbH, a leading, global provider of viral vector-based technologies that drive improved delivery performance for cell and gene therapies. The acquisition is expected to close during the third quarter of 2021. Headquartered in Munich, Germany, privately held SIRION has approximately 50 employees based […]

  • Oxford Instruments

    Oxford Instruments Buys WITec

    Oxford Instruments plc has announced the acquisition of WITec Wissenschaftliche Instrumente und Technologie GmbH, a leading provider of Raman microscopy imaging solutions, based in Ulm, Germany, for a cash-free, debt-free consideration of €42m, of which €5m is conditional on trading performance over a period of 12 months following completion. The acquisition is in line with […]

  • Tecan Logo

    Tecan Reports Financials for 2020

    Based on strong demand for COVID-19-related products, Tecan Group has reported significant growth in sales and profits in an exceptional and demanding year 2020. The company recorded a surge in orders for product lines supporting the global fight against the coronavirus pandemic. Full-year order entry increased by 33.9% to CHF 855.2 million (2019: CHF 638.6 […]

  • Zeiss logo

    ZEISS Acquires Majority Stake in arivis AG

    ZEISS Acquires Majority Stake in arivis AG ZEISS has announced the acquisition of a majority stake in the imaging business of arivis. With this investment, the company is further strengthening its software competencies and market position in 3D image visualisation, image processing, and analysis software for research microscopy. Both companies have a long-standing collaboration and […]

  • PerkinElmer to Acquire Horizon Discovery

    PerkinElmer (Waltham, MA, USA) and Horizon Discovery (Cambridge, UK) have announced an agreement whereby PerkinElmer will acquire Horizon for approximately $383 million (£296 million). The transaction is expected to close in the first quarter of 2021. Horizon is a leading provider of CRISPR and RNAi reagents, cell models, cell engineering and base editing offerings which […]

  • Thermo and Qiagen Agree Terms

    Thermo Fisher and Qiagen Agree Terms for Acquisition Thermo Fisher Scientific Inc. and QIAGEN N.V. have announced that they have entered into an amendment to their acquisition agreement under which Thermo Fisher has commenced a tender offer to acquire all of the ordinary shares of QIAGEN. The amendment increases the original offer price of €39.00 […]

  • Perkin Elmer Updates Q2 Outlook

    Perkin Elmer Updates Q2 Outlook Perkin Elmer has today revised their outlook for Q2, announcing that they expect growth of approximately 12% for the second quarter ended July 5, 2020. The strong revenue growth was driven by better-than-expected demand for solutions aimed at COVID-19 testing needs across the globe. Demand for the Company’s RT-PCR and […]

  • Danaher Completes Sale of Business Units to Sartorius

    Danaher Corporation has announced today the completion of the sale of some of its businesses to Sartorius AG for a consideration of $825 million. The sale was a requirement in order to obtain regulatory approval for Danaher’s acquisition of the GE Biopharma business, now called Cytiva. The sale included its label-free biomolecular characterization, chromatography hardware […]

  • Waters Results Hit by COVID-19

    Waters Corp. (Milford, Mass.) today reported their Q1 results for FY 2020. The quarter has been adversely impacted by the Coronavirus, notably in China early in the quarter, and later in Europe, the Americas and India. Sales declined by 10% to $465m although 2% of this was due to negative currency effects, but the company […]